Fc receptor-mediated immune effector cell activation

“Immune effector cell activation via Fc region” refers to activation of leukocyte effector functions when the Fc region of antigen-bound antibodies engages Fc receptors (primarily Fcγ receptors) on immune cells such as NK cells, macrophages, neutrophils, dendritic cells, and others[1][4]. This interaction clusters activating FcγRs and triggers intracellular immunoreceptor tyrosine-based activation motif (ITAM) signaling, leading to functions including antibody-dependent cellular cytotoxicity (via NK cell CD16/FcγRIII), antibody-dependent cellular phagocytosis (via macrophage FcγRs), cytokine production, and enhanced antigen uptake and presentation by antigen-presenting cells; inhibitory FcγRIIB contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) that down-modulates activation when co-aggregated[1][2][3][4]. Therapeutic antibodies frequently rely on these Fc-dependent mechanisms for efficacy, and the magnitude and quality of effector activation are shaped by antibody isotype/subclass, Fc glycosylation, Fc receptor genetics and expression, and the epitope’s position relative to the target cell membrane[4][6].

Other names

Fc receptor activationFc–Fc receptor interactionsFc-mediated effector functionAntibody Fc effector functionFcγ receptor signalingAntibody-dependent effector functions (ADCC, ADCP, CDC)

Engagement of activating Fcγ receptors (FcγRI, FcγRIIA, FcγRIIC, FcγRIIIA) leading to ITAM phosphorylation and downstream effector functions (ADCC, ADCP, cytokine release) Modulation through inhibitory FcγRIIB via ITIM signaling that dampens activation when co-aggregated with activating receptors or BCR Determinants of Fc-mediated activity include IgG subclass, Fc glycosylation, FcR polymorphisms and expression, epitope location/geometry, and immune complex stoichiometry